


莫德纳(MRNA.US)盘初一度涨超4%,最高触及34.17美元。消息面上,莫德纳宣布,美国食品药品监督管理局(FDA)已批准COVID-19疫苗Spikevax的补充生物制品许可证申请,适用于6个月至11岁高风险儿童。(格隆汇)
“特别声明:以上作品内容(包括在内的视频、图片或音频)为凤凰网旗下自媒体平台“大风号”用户上传并发布,本平台仅提供信息存储空间服务。
Notice: The content above (including the videos, pictures and audios if any) is uploaded and posted by the user of Dafeng Hao, which is a social media platform and merely provides information storage space services.”